相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: A pilot-study
Josef Marksteiner et al.
EXPERIMENTAL GERONTOLOGY (2014)
A literature review of AD7c-ntp as a biomarker for Alzheimer's disease
Jian Zhang et al.
ANNALS OF INDIAN ACADEMY OF NEUROLOGY (2013)
Neuroimaging and Other Biomarkers for Alzheimer's Disease: The Changing Landscape of Early Detection
Shannon L. Risacher et al.
ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 9 (2013)
Plasma and Serum from Nonfasting Men and Women Differ in Their Lipidomic Profiles
Masaki Ishikawa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2013)
Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease
David J. Irwin et al.
FRONTIERS IN AGING NEUROSCIENCE (2013)
An insight into iTRAQ: where do we stand now?
Caroline Evans et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2012)
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease
William T. Hu et al.
NEUROLOGY (2012)
Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease
Xu-Hua Xu et al.
NEUROSCIENCE BULLETIN (2012)
Stopping a thief and killer: Alzheimer's disease crisis demands greater commitment to research
William Thies
ALZHEIMERS & DEMENTIA (2011)
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2011)
The projected effect of risk factor reduction on Alzheimer's disease prevalence
Deborah E. Barnes et al.
LANCET NEUROLOGY (2011)
Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease
Josef Marksteiner et al.
NEUROBIOLOGY OF AGING (2011)
Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease
Richard J. Perrin et al.
PLOS ONE (2011)
Vascular Contributions to Cognitive Impairment and Dementia A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Philip B. Gorelick et al.
STROKE (2011)
Identifying and validating biomarkers for Alzheimer's disease
Christian Humpel
TRENDS IN BIOTECHNOLOGY (2011)
Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease
Madhav Thambisetty et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Transthyretin as a potential CSF biomarker for Alzheimer's disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors
K. Schultz et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Blood cell markers in Alzheimer Disease: Amyloid Precursor Protein form ratio in platelets
Barbara Borroni et al.
EXPERIMENTAL GERONTOLOGY (2010)
Amyloid beta and APP as biomarkers for Alzheimer's disease
Henrik Zetterberg et al.
EXPERIMENTAL GERONTOLOGY (2010)
Blood-based biomarkers of microvascular pathology in Alzheimer's disease
Michael Ewers et al.
EXPERIMENTAL GERONTOLOGY (2010)
Total and phosphorylated tau protein as biological markers of Alzheimer's disease
Harald Hampel et al.
EXPERIMENTAL GERONTOLOGY (2010)
Biomarkers for Alzheimer's disease and other forms of dementia: Clinical needs, limitations and future aspects
Angel Cedazo-Minguez et al.
EXPERIMENTAL GERONTOLOGY (2010)
Recent cerebrospinal fluid biomarker studies of Alzheimer's disease
Yong Seok Choi et al.
EXPERT REVIEW OF PROTEOMICS (2010)
Overexpression of Human Apolipoprotein A-I Preserves Cognitive Function and Attenuates Neuroinflammation and Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer Disease
Terry L. Lewis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
Identifying Early Markers of Alzheimer's Disease using Quantitative Multiplex Proteomic Immunoassay Panels
Holly D. Soares et al.
BIOMARKERS IN BRAIN DISEASE (2009)
B-type natriuretic peptide plasma levels are elevated in subcortical vascular dementia
Daniel Kondziella et al.
NEUROREPORT (2009)
Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease
Harald Hampel et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2009)
Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease
Henrik Zetterberg et al.
ARCHIVES OF NEUROLOGY (2008)
Tau as a biomarker of neuro degenerative diseases
Susanna Schraen-Maschke et al.
BIOMARKERS IN MEDICINE (2008)
Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease
Madhav Thambisetty et al.
JOURNAL OF NEUROLOGY (2008)
Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity
Mark R. Wilson et al.
MOLECULAR BIOSYSTEMS (2008)
Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI:: A multicenter study
Piotr Lewczuk et al.
NEUROBIOLOGY OF AGING (2008)
Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimer's disease patients and healthy individuals
Carina Sihlbom et al.
NEUROCHEMICAL RESEARCH (2008)
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Sandip Ray et al.
NATURE MEDICINE (2007)
Proteomics of human cerebrospinal fluid - the good, the bad, and the ugly
Jing Zhang
PROTEOMICS CLINICAL APPLICATIONS (2007)
The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures
Justin J. Yerbury et al.
FASEB JOURNAL (2007)
Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: Beta-amyloid(1-42), tau, phospho-tau-181 and total protein
Josef Marksteiner et al.
DRUGS OF TODAY (2007)
Multiplexed proteomic analysis of oxidation and concentrations of cerebrospinal fluid proteins in Alzheimer disease
Minna A. Korolainen et al.
CLINICAL CHEMISTRY (2007)
Prevalence of dementia in the united states: The aging, demographics, and memory study
B. L. Plassman et al.
NEUROEPIDEMIOLOGY (2007)
CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies
M. Bibl et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Proteome-based plasma biomarkers for Alzheimer's disease
A. Hye et al.
BRAIN (2006)
Amyloid-β peptide remnants in AN-1792-immunized Alzheimer's disease patients -: A biochemical analysis
R. Lyle Patton et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Clusterin in cerebrospinal fluid:: Analysis of carbohydrates and quantification of native and glycosylated forms
A. -M. Nilselid et al.
NEUROCHEMISTRY INTERNATIONAL (2006)
Plasma homocysteine and vascular disease in psychogeriatric patients
K Nilsson et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2006)
Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias
I Blasko et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2006)
Oxidative stress in brain aging, neurodegenerative and vascular diseases: An overview
E Mariani et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2005)
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis
A Stefani et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Plasma amyloid β protein 42 in non-demented persons aged 75 years:: Effects of concomitant medication and medial temporal lobe atrophy
I Blasko et al.
NEUROBIOLOGY OF AGING (2005)
Amyloid β 38, 40, and 42 species in cerebrospinal fluid:: more of the same?
NS Schoonenboom et al.
ANNALS OF NEUROLOGY (2005)
Alzheimer's Disease-Associated Neurotoxic Mechanisms and Neuroprotective Strategies
C. Pereira et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2005)
CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment
K Blennow
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2005)
Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain
DA Butterfield
BRAIN RESEARCH (2004)
Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease
F Colciaghi et al.
NEUROLOGY (2004)
Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs
MS Forman et al.
NATURE MEDICINE (2004)
Plasma levels of amyloid β-protein 42 are increased in women with mild cognitive impairment
A Assini et al.
NEUROLOGY (2004)
Impact of gender on upregulation of antioxidant defence mechanisms in Alzheimer's disease brain
K Schuessel et al.
JOURNAL OF NEURAL TRANSMISSION (2004)
Techniques for studying protein heterogeneity and post-translational modifications
M Baumann et al.
EXPERT REVIEW OF PROTEOMICS (2004)
Mining biomarkers in human sera using proteomic tools
RL Zhang et al.
PROTEOMICS (2004)
Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases
DJ Selkoe
NATURE CELL BIOLOGY (2004)
The human complement factor H:: functional roles, genetic variations and disease associations
SR de Córdoba et al.
MOLECULAR IMMUNOLOGY (2004)
Cerebrospinal fluid markers for prediction of Alzheimer's disease
H Zetterberg et al.
NEUROSCIENCE LETTERS (2003)
Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease
M Puchades et al.
MOLECULAR BRAIN RESEARCH (2003)
APP processing is regulated by cytoplasmic phosphorylation
MS Lee et al.
JOURNAL OF CELL BIOLOGY (2003)
Alzheimer disease in the US population - Prevalence estimates using the 2000 census
LE Hebert et al.
ARCHIVES OF NEUROLOGY (2003)
Identification of oxidized plasma proteins in Alzheimer's disease
JG Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics
SE Ong et al.
MOLECULAR & CELLULAR PROTEOMICS (2002)
Ubiquitin-proteasome pathway is compromised in CD45RO(+) and CD45RA(+) T lymphocyte subsets during aging
U Ponnappan
EXPERIMENTAL GERONTOLOGY (2002)
Low cerebrospinal fluid β-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment
M Sjögren et al.
NEUROSCIENCE LETTERS (2001)
Total antioxidant levels, gender, and age as risk factors for DNA damage in lymphocytes of the elderly
VM Mendoza-Núñez et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2001)
Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice
N Andreasen et al.
ARCHIVES OF NEUROLOGY (2001)
Alzheimer-Associated neuronal thread protein-induced apoptosis and impaired mitochondrial function in human central nervous system-derived neuronal cells
SM de la Monte et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
Detection of complement alternative pathway mRNA and proteins in the Alzheimer's disease brain
R Strohmeyer et al.
MOLECULAR BRAIN RESEARCH (2000)
Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology
SP Gygi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Cerebrospinal beta-amyloid (1-42) in early Alzheimer's disease:: association with apolipoprotein E genotype and cognitive decline
M Riemenschneider et al.
NEUROSCIENCE LETTERS (2000)
Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF
PJ Kahle et al.
NEUROLOGY (2000)
Decreased β-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
M Otto et al.
NEUROLOGY (2000)
CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging
M Sjogren et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
分享论文
